ArticleBone marrow transplantation2006

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.

G Juliusson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.